PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32349283-0	2020	Fingolimod Modulates Dendritic Architecture in a BDNF-Dependent Manner.	Fingolimod Hydrochloride	0-10	brain derived neurotrophic factor	Mus musculus	49-53	
32349283-3	2020	Among the different therapeutic strategies developed to improve endogenous BDNF levels is the administration of the BDNF-inducing drug Fingolimod, an agonist of the sphingosine-1-phosphate receptor.	Fingolimod Hydrochloride	135-145	brain derived neurotrophic factor	Mus musculus	75-79	
32349283-3	2020	Among the different therapeutic strategies developed to improve endogenous BDNF levels is the administration of the BDNF-inducing drug Fingolimod, an agonist of the sphingosine-1-phosphate receptor.	Fingolimod Hydrochloride	135-145	brain derived neurotrophic factor	Mus musculus	116-120	
32349283-5	2020	However, the cellular mechanisms through which Fingolimod mediates its BDNF-dependent therapeutic effects remain unclear.	Fingolimod Hydrochloride	47-57	brain derived neurotrophic factor	Mus musculus	71-75	
32349283-8	2020	Importantly, we show that BDNF release is required for these actions of Fingolimod.	Fingolimod Hydrochloride	72-82	brain derived neurotrophic factor	Mus musculus	26-30	
32349283-11	2020	Our study provides insights into understanding the BDNF-dependent therapeutic actions of Fingolimod.	Fingolimod Hydrochloride	89-99	brain derived neurotrophic factor	Mus musculus	51-55